Differential regulation of fibroblast growth factor receptor 1 trafficking and function by extracellular galectins

被引:0
作者
Marika Kucińska
Natalia Porębska
Agata Lampart
Marta Latko
Agata Knapik
Małgorzata Zakrzewska
Jacek Otlewski
Łukasz Opaliński
机构
[1] University of Wroclaw,Faculty of Biotechnology, Department of Protein Engineering
来源
Cell Communication and Signaling | / 17卷
关键词
Cell proliferation; Galectins; FGFR1; Receptor clustering; Signaling; Apoptosis;
D O I
暂无
中图分类号
学科分类号
摘要
Fibroblast growth factor receptors (FGFRs) are integral membrane proteins that transmit signals through the plasma membrane. FGFRs signaling needs to be precisely adjusted as aberrant FGFRs function is associated with development of human cancers or severe metabolic diseases. The subcellular localization, trafficking and function of FGFRs rely on the formation of multiprotein complexes. In this study we revealed galectins, lectin family members implicated in cancer development and progression, as novel FGFR1 binding proteins. We demonstrated that galectin-1 and galectin-3 directly bind to the sugar chains of the glycosylated extracellular part of FGFR1. Although both galectins compete for the same binding sites on FGFR1, these proteins elicit different impact on FGFR1 function and cellular trafficking. Galectin-1 mimics fibroblast growth factor as it efficiently activates FGFR1 and receptor-downstream signaling pathways that result in cell proliferation and apoptotic evasion. In contrast, galectin-3 induces extensive clustering of FGFR1 on the cell surface that inhibits constitutive internalization of FGFR1. Our data point on the interplay between extracellular galectins and FGFRs in the regulation of cell fate.
引用
收藏
相关论文
共 356 条
[1]  
Ornitz DM(2015)The fibroblast growth factor signaling pathway Wiley Interdiscip Rev Dev Biol 4 215-266
[2]  
Itoh N(2014)The ins and outs of fibroblast growth factor receptor signalling Clin Sci (Lond) 127 217-231
[3]  
Coleman SJ(2015)Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction Trends Cell Biol 25 221-233
[4]  
Bruce C(2018)Fibroblast growth factor receptors as treatment targets in clinical oncology Nat Rev Clin Oncol 16 105-122
[5]  
Chioni AM(2016)Targeting the fibroblast growth factor receptor family in cancer Cancer Treat Rev 46 51-62
[6]  
Kocher HM(2018)Targeting Cellular Trafficking of Fibroblast Growth Factor Receptors as a Strategy for Selective Cancer Treatment Journal of Clinical Medicine 8 7-332
[7]  
Grose RP(2017)Advances and challenges in targeting FGFR signalling in cancer Nat Rev Cancer 17 318-1110
[8]  
Carter EP(2010)Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer Sci Transl Med 2 62ra93-3893
[9]  
Fearon AE(2012)Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer Nat Genet 44 1104-6662
[10]  
Grose RP(2016)FGFR1 is a potential prognostic biomarker and therapeutic target in head and neck squamous cell carcinoma Clin Cancer Res 22 3884-1568